In their natural environments, cells are regularly exposed to oxidizing conditions that may lead to protein misfolding. If such misfolded proteins are allowed to linger, they may form insoluble aggregates and pose a serious threat to the cell. Accumulation of misfolded, oxidatively damaged proteins is characteristic of many diseases and during aging. To counter the adverse effects of oxidative stress, cells can initiate an antioxidative response in an attempt to repair the damage, or rapidly channel the damaged proteins for degradation by the ubiquitin-proteasome system (UPS). Recent studies have shown that elements of the oxidative stress response and the UPS are linked on many levels. To manage the extra burden of misfolded proteins, the UPS is induced by oxidative stress, and special proteasome subtypes protect cells against oxidative damage. In addition, the proteasome is directly associated with a thioredoxin and other cofactors that may adjust the particle's response during an oxidative challenge. Here, we give an overview of the UPS and a detailed description of the degradation of oxidized proteins and of the crosstalk between oxidative stress and protein degradation in health and disease. Antioxid. Redox Signal. 15, 2265–2299.
AdamsJ. The development of proteasome inhibitors as anticancer drugs. Cancer Cell, 5:417–421. 2004.
2.
AhmedEK, Rogowska-WrzesinskaA, RoepstorffP, BulteauAL, FriguetB. Protein modification and replicative senescence of WI-38 human embryonic fibroblasts. Aging Cell, 9:252–272. 2010.
3.
AkiM, ShimbaraN, TakashinaM, AkiyamaK, KagawaS, TamuraT, TanahashiN, YoshimuraT, TanakaK, IchiharaA. Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J Biochem, 115:257–269. 1994.
4.
AndersenKM, JensenC, KriegenburgF, LauridsenA-MB, GordonC, Hartmann-PetersenR. Txl1 and Txc1 are co-factors of the 26S proteasome in fission yeast. Antioxid Redox Signal, 14:1601–1608. 2011.
5.
AndersenKM, MadsenL, PragS, JohnsenAH, SempleCA, HendilKB, Hartmann-PetersenR. Thioredoxin Txnl1/TRP32 is a redox-active cofactor of the 26 S proteasome. J Biol Chem, 284:15246–15254. 2009.
6.
ArltA, BauerI, SchafmayerC, TepelJ, MuerkosterSS, BroschM, RoderC, KalthoffH, HampeJ, MoyerMP, FolschUR, SchaferH. Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)Oncogene, 28:3983–3996. 2009.
ArndtV, RogonC, HohfeldJ. To be, or not to be—molecular chaperones in protein degradation. Cell Mol Life Sci, 64:2525–2541. 2007.
9.
ArrigoAP, TanakaK, GoldbergAL, WelchWJ. Identity of the 19S ‘prosome’ particle with the large multifunctional protease complex of mammalian cells (the proteasome)Nature, 331:192–194. 1988.
10.
AsherG, LotemJ, CohenB, SachsL, ShaulY. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc Natl Acad Sci U S A, 98:1188–1193. 2001.
11.
AsherG, ShaulY. p53 proteasomal degradation: poly-ubiquitination is not the whole story. Cell Cycle, 4:1015–1018. 2005.
12.
AzzuV, BrandMD. Degradation of an intramitochondrial protein by the cytosolic proteasome. J Cell Sci, 123:578–585. 2010.
13.
BaderN, JungT, GruneT. The proteasome and its role in nuclear protein maintenance. Exp Gerontol, 42:864–870. 2007.
14.
BalogEM, LockamyEL, ThomasDD, FerringtonDA. Site-specific methionine oxidation initiates calmodulin degradation by the 20S proteasome. Biochemistry, 48:3005–3016. 2009.
Bardag-GorceF, LiJ, FrenchBA, FrenchSW. The effect of ethanol-induced CYP2E1 on proteasome activity: the role of 4-hydroxynonenal. Exp Mol Pathol, 78:109–115. 2005.
17.
BaughJM, ViktorovaEG, PilipenkoEV. Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination. J Mol Biol, 386:814–827. 2009.
18.
BealR, DeverauxQ, XiaG, RechsteinerM, PickartC. Surface hydrophobic residues of multiubiquitin chains essential for proteolytic targeting. Proc Natl Acad Sci U S A, 93:861–866. 1996.
19.
BedfordL, LoweJ, DickLR, MayerRJ, BrownellJE. Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov, 10:29–46. 2011.
BraunBC, GlickmanM, KraftR, DahlmannB, KloetzelPM, FinleyD, SchmidtM. The base of the proteasome regulatory particle exhibits chaperone-like activity. Nat Cell Biol, 1:221–226. 1999.
30.
BreusingN, GruneT. Regulation of proteasome-mediated protein degradation during oxidative stress and aging. Biol Chem, 389:203–209. 2008.
31.
BrooksP, FuertesG, MurrayRZ, BoseS, KnechtE, RechsteinerMC, HendilKB, TanakaK, DysonJ, RivettJ. Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem J, 346,Pt 1:155–161. 2000.
32.
BulteauAL, LundbergKC, HumphriesKM, SadekHA, SzwedaPA, FriguetB, SzwedaLI. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem, 276:30057–30063. 2001.
33.
CabreraR, ShaZ, VadakkanTJ, OteroJ, KriegenburgF, Hartmann-PetersenR, DickinsonME, ChangEC. Proteasome nuclear import mediated by Arc3 can influence efficient DNA damage repair and mitosis in Schizosaccharomyces pombe. Mol Biol Cell, 21:3125–3136. 2010.
34.
CallahanMK, WohlfertEA, MenoretA, SrivastavaPK. Heat shock up-regulates lmp2 and lmp7 and enhances presentation of immunoproteasome-dependent epitopes. J Immunol, 177:8393–8399. 2006.
35.
CarlucciA, LignittoL, FelicielloA. Control of mitochondria dynamics and oxidative metabolism by cAMP, AKAPs and the proteasome. Trends Cell Biol, 18:604–613. 2008.
36.
CarrardG, BulteauAL, PetropoulosI, FriguetB. Impairment of proteasome structure and function in aging. Int J Biochem Cell Biol, 34:1461–1474. 2002.
37.
CarrardG, DieuM, RaesM, ToussaintO, FriguetB. Impact of ageing on proteasome structure and function in human lymphocytes. Int J Biochem Cell Biol, 35:728–739. 2003.
38.
CatalgolB, GruneT. Protein pool maintenance during oxidative stress. Curr Pharm Des, 15:3043–3051. 2009.
39.
CecariniV, DingQ, KellerJN. Oxidative inactivation of the proteasome in Alzheimer's disease. Free Radic Res, 41:673–680. 2007.
CenciS, SitiaR. Managing and exploiting stress in the antibody factory. FEBS Lett, 581:3652–3657. 2007.
42.
ChanJY, KwongM, LuR, ChangJ, WangB, YenTS, KanYW. Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. EMBO J, 17:1779–1787. 1998.
43.
ChandraJ. Oxidative stress by targeted agents promotes cytotoxicity in hematologic malignancies. Antioxid Redox Signal, 11:1123–1137. 2009.
44.
ChaoCC, MaYS, StadtmanER. Modification of protein surface hydrophobicity and methionine oxidation by oxidative systems. Proc Natl Acad Sci U S A, 94:2969–2974. 1997.
45.
ChenL, MaduraK. Increased proteasome activity, ubiquitin-conjugating enzymes, and eEF1A translation factor detected in breast cancer tissue. Cancer Res, 65:5599–5606. 2005.
46.
ChenX, BartonLF, ChiY, ClurmanBE, RobertsJM. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol Cell, 26:843–852. 2007.
47.
ChengL, WattR, PiperPW. Polyubiquitin gene expression contributes to oxidative stress resistance in respiratory yeast (Saccharomyces cerevisiae)Mol Gen Genet, 243:358–362. 1994.
ChinDT, KuehlL, RechsteinerM. Conjugation of ubiquitin to denatured hemoglobin is proportional to the rate of hemoglobin degradation in HeLa cells. Proc Natl Acad Sci U S A, 79:5857–5861. 1982.
50.
ChondrogianniN, GonosES. Proteasome dysfunction in mammalian aging: steps and factors involved. Exp Gerontol, 40:931–938. 2005.
51.
ChondrogianniN, GonosES. Overexpression of hUMP1/POMP proteasome accessory protein enhances proteasome-mediated antioxidant defence. Exp Gerontol, 42:899–903. 2007.
52.
ChondrogianniN, GonosES. Proteasome activation as a novel antiaging strategy. IUBMB Life, 60:651–655. 2008.
53.
ChouB, HisaedaH, ShenJ, DuanX, ImaiT, TuL, MurataS, TanakaK, HimenoK. Critical contribution of immunoproteasomes in the induction of protective immunity against Trypanosoma cruzi in mice vaccinated with a plasmid encoding a CTL epitope fused to green fluorescence protein. Microbes Infect, 10:241–250. 2008.
CiechanoverA. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Cell Death Differ, 12:1178–1190. 2005.
56.
CohenMM, LeboucherGP, Livnat-LevanonN, GlickmanMH, WeissmanAM. Ubiquitin-proteasome-dependent degradation of a mitofusin, a critical regulator of mitochondrial fusion. Mol Biol Cell, 19:2457–2464. 2008.
57.
CombsCK, KarloJC, KaoSC, LandrethGE. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci, 21:1179–1188. 2001.
58.
ConconiM, FriguetB. Proteasome inactivation upon aging and on oxidation-effect of HSP 90. Mol Biol Rep, 24:45–50. 1997.
59.
ConconiM, PetropoulosI, EmodI, TurlinE, BivilleF, FriguetB. Protection from oxidative inactivation of the 20S proteasome by heat-shock protein 90. Biochem J, 333,Pt 2:407–415. 1998.
60.
CookC, GassJ, DunmoreJ, TongJ, TaylorJ, EriksenJ, McGowanE, LewisJ, JohnstonJ, PetrucelliL. Aging is not associated with proteasome impairment in UPS reporter mice. PLoS One, 4:e5888. 2009.
61.
CostaV, QuintanilhaA, Moradas-FerreiraP. Protein oxidation, repair mechanisms and proteolysis in Saccharomyces cerevisiae. IUBMB Life, 59:293–298. 2007.
62.
CouxO, TanakaK, GoldbergAL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem, 65:801–847. 1996.
63.
CrosasB, HannaJ, KirkpatrickDS, ZhangDP, ToneY, HathawayNA, BueckerC, LeggettDS, SchmidtM, KingRW, GygiSP, FinleyD. Ubiquitin chains are remodeled at the proteasome by opposing ubiquitin ligase and deubiquitinating activities. Cell, 127:1401–1413. 2006.
64.
DantumaNP, GroothuisTA, SalomonsFA, NeefjesJ. A dynamic ubiquitin equilibrium couples proteasomal activity to chromatin remodeling. J Cell Biol, 173:19–26. 2006.
65.
DantumaNP, LindstenK. Stressing the ubiquitin-proteasome system. Cardiovasc Res, 85:263–271. 2010.
66.
DaviesKJ. Free radicals and protein degradation in human red blood cells. Prog Clin Biol Res, 195:15–27. 1985.
67.
DaviesKJ. Intracellular proteolytic systems may function as secondary antioxidant defenses: an hypothesis. J Free Radic Biol Med, 2:155–173. 1986.
68.
DaviesKJ. Degradation of oxidized proteins by the 20S proteasome. Biochimie, 83:301–310. 2001.
69.
DaviesKJ, GoldbergAL. Oxygen radicals stimulate intracellular proteolysis and lipid peroxidation by independent mechanisms in erythrocytes. J Biol Chem, 262:8220–8226. 1987.
70.
DaviesKJ, GoldbergAL. Proteins damaged by oxygen radicals are rapidly degraded in extracts of red blood cells. J Biol Chem, 262:8227–8234. 1987.
71.
DaviesKJ, LinSW. Oxidatively denatured proteins are degraded by an ATP-independent proteolytic pathway in Escherichia coli. Free Radic Biol Med, 5:225–236. 1988.
72.
DaviesKJ, LinSW, PacificiRE. Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein. J Biol Chem, 262:9914–9920. 1987.
73.
DemasiM, ShringarpureR, DaviesKJ. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors. Arch Biochem Biophys, 389:254–263. 2001.
74.
DemasiM, SilvaGM, NettoLE. 20 S proteasome from Saccharomyces cerevisiae is responsive to redox modifications and is S-glutathionylated. J Biol Chem, 278:679–685. 2003.
75.
DenuJM, TannerKG. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry, 37:5633–5642. 1998.
76.
DeolP, ZaissDM, MonacoJJ, SijtsAJ. Rates of processing determine the immunogenicity of immunoproteasome-generated epitopes. J Immunol, 178:7557–7562. 2007.
77.
DeshaiesRJ, JoazeiroCA. RING domain E3 ubiquitin ligases. Annu Rev Biochem, 78:399–434. 2009.
78.
DeverauxQ, UstrellV, PickartC, RechsteinerM. A 26 S protease subunit that binds ubiquitin conjugates. J Biol Chem, 269:7059–7061. 1994.
79.
Diaz-HernandezM, HernandezF, Martin-AparicioE, Gomez-RamosP, MoranMA, CastanoJG, FerrerI, AvilaJ, LucasJJ. Neuronal induction of the immunoproteasome in Huntington's disease. J Neurosci, 23:11653–11661. 2003.
80.
DickTP, RuppertT, GroettrupM, KloetzelPM, KuehnL, KoszinowskiUH, StevanovicS, SchildH, RammenseeHG. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell, 86:253–262. 1996.
81.
DikicI, WakatsukiS, WaltersKJ. Ubiquitin-binding domains - from structures to functions. Nat Rev Mol Cell Biol, 10:659–671. 2009.
82.
DodsonMW, GuoM. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease. Curr Opin Neurobiol, 17:331–337. 2007.
83.
DownesB, VierstraRD. Post-translational regulation in plants employing a diverse set of polypeptide tags. Biochem Soc Trans, 33:393–399. 2005.
84.
DregerH, WestphalK, WellerA, BaumannG, StanglV, MeinersS, StanglK. Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection. Cardiovasc Res, 83:354–361. 2009.
85.
DregerH, WestphalK, WilckN, BaumannG, StanglV, StanglK, MeinersS. Protection of vascular cells from oxidative stress by proteasome inhibition depends on Nrf2. Cardiovasc Res, 85:395–403. 2010.
86.
DrogeW. Free radicals in the physiological control of cell function. Physiol Rev, 82:47–95. 2002.
87.
DudekEJ, ShangF, ValverdeP, LiuQ, HobbsM, TaylorA. Selectivity of the ubiquitin pathway for oxidatively modified proteins: relevance to protein precipitation diseases. FASEB J, 19:1707–1709. 2005.
EnchevRI, SchreiberA, BeuronF, MorrisEP. Structural insights into the COP9 signalosome and its common architecture with the 26S proteasome lid and eIF3. Structure, 18:518–527. 2010.
90.
EnenkelC, LehmannA, KloetzelPM. Subcellular distribution of proteasomes implicates a major location of protein degradation in the nuclear envelope-ER network in yeast. EMBO J, 17:6144–6154. 1998.
91.
EnyediB, VarnaiP, GeisztM. Redox state of the endoplasmic reticulum is controlled by Ero1L-alpha and intraluminal calcium. Antioxid Redox Signal, 13:721–729. 2010.
92.
FabunmiRP, WigleyWC, ThomasPJ, DeMartinoGN. Activity and regulation of the centrosome-associated proteasome. J Biol Chem, 275:409–413. 2000.
93.
FaganJM, WaxmanL, GoldbergAL. Red blood cells contain a pathway for the degradation of oxidant-damaged hemoglobin that does not require ATP or ubiquitin. J Biol Chem, 261:5705–5713. 1986.
94.
FagioliC, MezghraniA, SitiaR. Reduction of interchain disulfide bonds precedes the dislocation of Ig-mu chains from the endoplasmic reticulum to the cytosol for proteasomal degradation. J Biol Chem, 276:40962–40967. 2001.
95.
FaroutL, MaryJ, VinhJ, SzwedaLI, FriguetB. Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. Arch Biochem Biophys, 453:135–142. 2006.
96.
FerranteRJ, AndreassenOA, DedeogluA, FerranteKL, JenkinsBG, HerschSM, BealMF. Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease. J Neurosci, 22:1592–1599. 2002.
97.
FerringtonDA, KapphahnRJ. Catalytic site-specific inhibition of the 20S proteasome by 4-hydroxynonenal. FEBS Lett, 578:217–223. 2004.
98.
FerringtonDA, SunH, MurrayKK, CostaJ, WilliamsTD, BigelowDJ, SquierTC. Selective degradation of oxidized calmodulin by the 20 S proteasome. J Biol Chem, 276:937–943. 2001.
99.
FinleyD. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem, 78:477–513. 2009.
100.
FinleyD, OzkaynakE, VarshavskyA. The yeast polyubiquitin gene is essential for resistance to high temperatures, starvation, and other stresses. Cell, 48:1035–1046. 1987.
101.
FlemingJA, LightcapES, SadisS, ThoroddsenV, BulawaCE, BlackmanRK. Complementary whole-genome technologies reveal the cellular response to proteasome inhibition by PS-341. Proc Natl Acad Sci U S A, 99:1461–1466. 2002.
102.
ForsterF, LaskerK, BeckF, NickellS, SaliA, BaumeisterW. An atomic model AAA-ATPase/20S core particle sub-complex of the 26S proteasome. Biochem Biophys Res Commun, 388:228–233. 2009.
103.
ForsterF, LaskerK, NickellS, SaliA, BaumeisterW. Toward an integrated structural model of the 26S proteasome. Mol Cell Proteomics, 9:1666–1677. 2010.
104.
FortunJ, DunnWAJr., JoyS, LiJ, NotterpekL. Emerging role for autophagy in the removal of aggresomes in Schwann cells. J Neurosci, 23:10672–10680. 2003.
FribleyA, ZengQ, WangCY. Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells. Mol Cell Biol, 24:9695–9704. 2004.
107.
FriguetB, SzwedaLI. Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein. FEBS Lett, 405:21–25. 1997.
108.
FrilingRS, BensimonA, TichauerY, DanielV. Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc Natl Acad Sci U S A, 87:6258–6262. 1990.
109.
FuchsD, BergesC, OpelzG, DanielV, NaujokatC. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells. J Cell Biochem, 103:270–283. 2008.
110.
GaoJ, YinD, YaoY, WilliamsTD, SquierTC. Progressive decline in the ability of calmodulin isolated from aged brain to activate the plasma membrane Ca-ATPase. Biochemistry, 37:9536–9548. 1998.
111.
Garcia-MataR, BebokZ, SorscherEJ, SztulES. Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. J Cell Biol, 146:1239–1254. 1999.
112.
Garcia-MataR, GaoYS, SztulE. Hassles with taking out the garbage: aggravating aggresomes. Traffic, 3:388–396. 2002.
113.
GechaOM, FaganJM. Protective effect of ascorbic acid on the breakdown of proteins exposed to hydrogen peroxide in chicken skeletal muscle. J Nutr, 122:2087–2093. 1992.
114.
GeislerS, HolmstromKM, SkujatD, FieselFC, RothfussOC, KahlePJ, SpringerW. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol, 12:119–131. 2010.
115.
GhaziA, Henis-KorenblitS, KenyonC. Regulation of Caenorhabditis elegans lifespan by a proteasomal E3 ligase complex. Proc Natl Acad Sci U S A, 104:5947–5952. 2007.
116.
GiudiceA, MontellaM. Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention. Bioessays, 28:169–181. 2006.
117.
GlickmanMH, CiechanoverA. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev, 82:373–428. 2002.
118.
GlickmanMH, RubinDM, CouxO, WefesI, PfeiferG, CjekaZ, BaumeisterW, FriedVA, FinleyD. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell, 94:615–623. 1998.
119.
GoldbergAL. Protein degradation and protection against misfolded or damaged proteins. Nature, 426:895–899. 2003.
120.
GoldbergAL, BochesFS. Oxidized proteins in erythrocytes are rapidly degraded by the adenosine triphosphate-dependent proteolytic system. Science, 215:1107–1109. 1982.
121.
Gonzalez-DosalR, SorensenMD, ClarkBF, RattanSI, KristensenP. Phage-displayed antibodies for the detection of glycated proteasome in aging cells. Ann N Y Acad Sci, 1067:474–478. 2006.
122.
GorbeaC, GoellnerGM, TeterK, HolmesRK, RechsteinerM. Characterization of mammalian Ecm29, a 26 S proteasome-associated protein that localizes to the nucleus and membrane vesicles. J Biol Chem, 279:54849–54861. 2004.
123.
GorbeaC, PrattG, UstrellV, BellR, SahasrabudheS, HughesRE, RechsteinerM. A protein interaction network for Ecm29 links the 26 S proteasome to molecular motors and endosomal components. J Biol Chem, 285:31616–31633. 2010.
124.
GordonC. The intracellular localization of the proteasome. Curr Top Microbiol Immunol, 268:175–184. 2002.
125.
GroettrupM, SozaA, EggersM, KuehnL, DickTP, SchildH, RammenseeHG, KoszinowskiUH, KloetzelPM. A role for the proteasome regulator PA28alpha in antigen presentation. Nature, 381:166–168. 1996.
126.
GrollM, BajorekM, KohlerA, MoroderL, RubinDM, HuberR, GlickmanMH, FinleyD. A gated channel into the proteasome core particle. Nat Struct Biol, 7:1062–1067. 2000.
127.
GrollM, DitzelL, LoweJ, StockD, BochtlerM, BartunikHD, HuberR. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature, 386:463–471. 1997.
128.
GruneT, BlasigIE, SitteN, RoloffB, HaseloffR, DaviesKJ. Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome. J Biol Chem, 273:10857–10862. 1998.
129.
GruneT, ReinheckelT, DaviesKJ. Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome. J Biol Chem, 271:15504–15509. 1996.
130.
GruneT, ReinheckelT, DaviesKJ. Degradation of oxidized proteins in mammalian cells. FASEB J, 11:526–534. 1997.
131.
GruneT, ReinheckelT, JoshiM, DaviesKJ. Proteolysis in cultured liver epithelial cells during oxidative stress. Role of the multicatalytic proteinase complex, proteasome. J Biol Chem, 270:2344–2351. 1995.
132.
GuerreroC, MilenkovicT, PrzuljN, KaiserP, HuangL. Characterization of the proteasome interaction network using a QTAX-based tag-team strategy and protein interaction network analysis. Proc Natl Acad Sci U S A, 105:13333–13338. 2008.
133.
GuoD, HanJ, AdamBL, ColburnNH, WangMH, DongZ, EizirikDL, SheJX, WangCY. Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stress. Biochem Biophys Res Commun, 337:1308–1318. 2005.
134.
HaapasaloA, ViswanathanJ, BertramL, SoininenH, TanziRE, HiltunenM. Emerging role of Alzheimer's disease-associated ubiquilin-1 in protein aggregation. Biochem Soc Trans, 38:150–155. 2010.
135.
HahnJS, NeefDW, ThieleDJ. A stress regulatory network for co-ordinated activation of proteasome expression mediated by yeast heat shock transcription factor. Mol Microbiol, 60:240–251. 2006.
136.
HamerG, MatilainenO, HolmbergCI. A photoconvertible reporter of the ubiquitin-proteasome system in vivo. Nat Methods, 7:473–478. 2010.
137.
HannaJ, FinleyD. A proteasome for all occasions. FEBS Lett, 581:2854–2861. 2007.
138.
HannaJ, LeggettDS, FinleyD. Ubiquitin depletion as a key mediator of toxicity by translational inhibitors. Mol Cell Biol, 23:9251–9261. 2003.
139.
HansenRE, RothD, WintherJR. Quantifying the global cellular thiol-disulfide status. Proc Natl Acad Sci U S A, 106:422–427. 2009.
140.
HarmanD. Aging: overview. Ann N Y Acad Sci, 928:1–21. 2001.
141.
Hartmann-PetersenR, SeegerM, GordonC. Transferring substrates to the 26S proteasome. Trends Biochem Sci, 28:26–31. 2003.
142.
Hartmann-PetersenR, SempleCA, PontingCP, HendilKB, GordonC. UBA domain containing proteins in fission yeast. Int J Biochem Cell Biol, 35:629–636. 2003.
143.
HashimotoM, HsuLJ, XiaY, TakedaA, SiskA, SundsmoM, MasliahE. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. Neuroreport, 10:717–721. 1999.
144.
HeinkS, LudwigD, KloetzelPM, KrugerE. IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc Natl Acad Sci U S A, 102:9241–9246. 2005.
145.
HendilKB. The 19 S multicatalytic “prosome” proteinase is a constitutive enzyme in HeLa cells. Biochem Int, 17:471–477. 1988.
146.
HendilKB, KhanS, TanakaK. Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes. Biochem J, 332,Pt 3:749–754. 1998.
147.
HendilKB, KriegenburgF, TanakaK, MurataS, LauridsenAM, JohnsenAH, Hartmann-PetersenR. The 20S proteasome as an assembly platform for the 19S regulatory complex. J Mol Biol, 394:320–328. 2009.
148.
HensleyK, CarneyJM, MattsonMP, AksenovaM, HarrisM, WuJF, FloydRA, ButterfieldDA. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci U S A, 91:3270–3274. 1994.
149.
HermannJ, GulatiR, NapoliC, WoodrumJE, LermanLO, Rodriguez-PorcelM, SicaV, SimariRD, CiechanoverA, LermanA. Oxidative stress-related increase in ubiquitination in early coronary atherogenesis. FASEB J, 17:1730–1732. 2003.
HideshimaT, RichardsonP, ChauhanD, PalombellaVJ, ElliottPJ, AdamsJ, AndersonKC. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res, 61:3071–3076. 2001.
152.
HirschC, GaussR, HornSC, NeuberO, SommerT. The ubiquitylation machinery of the endoplasmic reticulum. Nature, 458:453–460. 2009.
153.
HoMS, OuC, ChanYR, ChienCT, PiH. The utility F-box for protein destruction. Cell Mol Life Sci, 65:1977–2000. 2008.
154.
HofmannK, BucherP. The UBA domain: a sequence motif present in multiple enzyme classes of the ubiquitination pathway. Trends Biochem Sci, 21:172–173. 1996.
155.
HosokawaN, WadaI, HasegawaK, YorihuziT, TremblayLO, HerscovicsA, NagataK. A novel ER alpha-mannosidase-like protein accelerates ER-associated degradation. EMBO Rep, 2:415–422. 2001.
156.
HusbergC, MurphyP, BjorgoE, KallandKH, KolstoAB. Cellular localisation and nuclear export of the human bZIP transcription factor TCF11. Biochim Biophys Acta, 1640:143–151. 2003.
InaiY, NishikimiM. Increased degradation of oxidized proteins in yeast defective in 26 S proteasome assembly. Arch Biochem Biophys, 404:279–284. 2002.
160.
IshiiK, HisaedaH, DuanX, ImaiT, SakaiT, FehlingHJ, MurataS, ChibaT, TanakaK, HamanoS, SanoM, YanoA, HimenoK. The involvement of immunoproteasomes in induction of MHC class I-restricted immunity targeting Toxoplasma SAG1. Microbes Infect, 8:1045–1053. 2006.
161.
IwaiK, DrakeSK, WehrNB, WeissmanAM, LaVauteT, MinatoN, KlausnerRD, LevineRL, RouaultTA. Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins. Proc Natl Acad Sci U S A, 95:4924–4928. 1998.
162.
Jahngen-HodgeJ, ObinMS, GongX, ShangF, NowellTRJr., GongJ, AbasiH, BlumbergJ, TaylorA. Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J Biol Chem, 272:28218–28226. 1997.
163.
JakobCA, BodmerD, SpirigU, BattigP, MarcilA, DignardD, BergeronJJ, ThomasDY, AebiM. Htm1p, a mannosidase-like protein, is involved in glycoprotein degradation in yeast. EMBO Rep, 2:423–430. 2001.
164.
JeanneM, Lallemand-BreitenbachV, FerhiO, KokenM, LeBM, DuffortS, PeresL, BerthierC, SoilihiH, RaughtB, deTH. PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3. Cancer Cell, 18:88–98. 2010.
165.
JiangHY, WekRC. Phosphorylation of the alpha-subunit of the eukaryotic initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition. J Biol Chem, 280:14189–14202. 2005.
166.
JohnsenO, MurphyP, PrydzH, KolstoAB. Interaction of the CNC-bZIP factor TCF11/LCR-F1/Nrf1 with MafG: binding-site selection and regulation of transcription. Nucleic Acids Res, 26:512–520. 1998.
167.
JohnsenO, SkammelsrudN, LunaL, NishizawaM, PrydzH, KolstoAB. Small Maf proteins interact with the human transcription factor TCF11/Nrf1/LCR-F1. Nucleic Acids Res, 24:4289–4297. 1996.
168.
JohnstonD, OppermannH, JacksonJ, LevinsonW. Induction of four proteins in chick embryo cells by sodium arsenite. J Biol Chem, 255:6975–6980. 1980.
169.
JohnstonJA, WardCL, KopitoRR. Aggresomes: a cellular response to misfolded proteins. J Cell Biol, 143:1883–1898. 1998.
170.
KahlePJ, HaassC. How does parkin ligate ubiquitin to Parkinson's disease?EMBO Rep, 5:681–685. 2004.
171.
KatoT, KawaharaA, AshidaH, YamamotoK. Unique peptide:N-glycanase of Caenorhabditis elegans has activity of protein disulphide reductase as well as of deglycosylation. J Biochem, 142:175–181. 2007.
172.
KeeneyPM, XieJ, CapaldiRA, BennettJPJr.Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci, 26:5256–5264. 2006.
173.
KellerJN, DimayugaE, ChenQ, ThorpeJ, GeeJ, DingQ. Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. Int J Biochem Cell Biol, 36:2376–2391. 2004.
174.
KenslerTW, WakabayashiN. Nrf2: friend or foe for chemoprevention?Carcinogenesis, 31:90–99. 2010.
KirkinV, McEwanDG, NovakI, DikicI. A role for ubiquitin in selective autophagy. Mol Cell, 34:259–269. 2009.
177.
KisselevAF, CallardA, GoldbergAL. Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate. J Biol Chem, 281:8582–8590. 2006.
178.
KisselevAF, GoldbergAL. Proteasome inhibitors: from research tools to drug candidates. Chem Biol, 8:739–758. 2001.
179.
KisselevAF, KaganovichD, GoldbergAL. Binding of hydrophobic peptides to several non-catalytic sites promotes peptide hydrolysis by all active sites of 20 S proteasomes. Evidence for peptide-induced channel opening in the alpha-rings. J Biol Chem, 277:22260–22270. 2002.
180.
KlareN, SeegerM, JanekK, JungblutPR, DahlmannB. Intermediate-type 20 S proteasomes in HeLa cells: “asymmetric” subunit composition, diversity and adaptation. J Mol Biol, 373:1–10. 2007.
181.
KloetzelPM. Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII. Nat Immunol, 5:661–669. 2004.
182.
KloetzelPM, OssendorpF. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr Opin Immunol, 16:76–81. 2004.
183.
KodadekT. No Splicing, no dicing: non-proteolytic roles of the ubiquitin-proteasome system in transcription. J Biol Chem, 285:2221–2226. 2010.
184.
KoeglM, HoppeT, SchlenkerS, UlrichHD, MayerTU, JentschS. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell, 96:635–644. 1999.
185.
KomanderD. The emerging complexity of protein ubiquitination. Biochem Soc Trans, 37:937–953. 2009.
186.
KomanderD, ClagueMJ, UrbeS. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol, 10:550–563. 2009.
187.
KomatsuM, WaguriS, ChibaT, MurataS, IwataJ, TanidaI, UenoT, KoikeM, UchiyamaY, KominamiE, TanakaK. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature, 441:880–884. 2006.
188.
KopitoRR. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol, 10:524–530. 2000.
189.
KorolchukVI, MenziesFM, RubinszteinDC. Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett, 584:1393–1398. 2010.
190.
KotamrajuS, MatalonS, MatsunagaT, ShangT, Hickman-DavisJM, KalyanaramanB. Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells. Free Radic Biol Med, 40:1034–1044. 2006.
KraftDC, DeocarisCC, WadhwaR, RattanSI. Preincubation with the proteasome inhibitor MG-132 enhances proteasome activity via the Nrf2 transcription factor in aging human skin fibroblasts. Ann N Y Acad Sci, 1067:420–424. 2006.
193.
KriegenburgF, SeegerM, SaekiY, TanakaK, LauridsenAM, Hartmann-PetersenR, HendilKB. Mammalian 26S proteasomes remain intact during protein degradation. Cell, 135:355–365. 2008.
194.
KrugerE, KuckelkornU, SijtsA, KloetzelPM. The components of the proteasome system and their role in MHC class I antigen processing. Rev Physiol Biochem Pharmacol, 148:81–104. 2003.
195.
KwakMK, WakabayashiN, GreenlawJL, YamamotoM, KenslerTW. Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol Cell Biol, 23:8786–8794. 2003.
196.
LamYA, LawsonTG, VelayuthamM, ZweierJL, PickartCM. A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal. Nature, 416:763–767. 2002.
197.
LambertAJ, BrandMD. Reactive oxygen species production by mitochondria. Methods Mol Biol, 554:165–181. 2009.
198.
LauA, WangXJ, ZhaoF, VilleneuveNF, WuT, JiangT, SunZ, WhiteE, ZhangDD. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol Cell Biol, 30:3275–3285. 2010.
199.
LeeBH, LeeMJ, ParkS, OhDC, ElsasserS, ChenPC, GartnerC, DimovaN, HannaJ, GygiSP, WilsonSM, KingRW, FinleyD. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature, 467:179–184. 2010.
200.
LeeMJ, LeeBH, HannaJ, KingRW, FinleyD. 2011. Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes. Mol Cell Proteomics(In press);DOI:10.1074/mcp.R110.003871.
LelouardH, FerrandV, MarguetD, BaniaJ, CamossetoV, DavidA, GattiE, PierreP. Dendritic cell aggresome-like induced structures are dedicated areas for ubiquitination and storage of newly synthesized defective proteins. J Cell Biol, 164:667–675. 2004.
203.
LevineRL, OliverCN, FulksRM, StadtmanER. Turnover of bacterial glutamine synthetase: oxidative inactivation precedes proteolysis. Proc Natl Acad Sci U S A, 78:2120–2124. 1981.
204.
LevineRL, WehrN, WilliamsJA, StadtmanER, ShacterE. Determination of carbonyl groups in oxidized proteins. Methods Mol Biol, 99:15–24. 2000.
205.
LevinsonW, OppermannH, JacksonJ. Transition series metals and sulfhydryl reagents induce the synthesis of four proteins in eukaryotic cells. Biochim Biophys Acta, 606:170–180. 1980.
206.
LiG, ZhaoG, ZhouX, SchindelinH, LennarzWJ. The AAA ATPase p97 links peptide N-glycanase to the endoplasmic reticulum-associated E3 ligase autocrine motility factor receptor. Proc Natl Acad Sci U S A, 103:8348–8353. 2006.
207.
LiG, ZhouX, ZhaoG, SchindelinH, LennarzWJ. Multiple modes of interaction of the deglycosylation enzyme, mouse peptide N-glycanase, with the proteasome. Proc Natl Acad Sci U S A, 102:15809–15814. 2005.
208.
LiW, BengtsonMH, UlbrichA, MatsudaA, ReddyVA, OrthA, ChandaSK, BatalovS, JoazeiroCA. Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling. PLoS One, 3:e1487. 2008.
209.
LiX, LonardDM, JungSY, MalovannayaA, FengQ, QinJ, TsaiSY, TsaiMJ, O'MalleyBW. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome. Cell, 124:381–392. 2006.
210.
LingYH, LiebesL, ZouY, Perez-SolerR. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells. J Biol Chem, 278:33714–33723. 2003.
211.
LiuCW, CorboyMJ, DeMartinoGN, ThomasPJ. Endoproteolytic activity of the proteasome. Science, 299:408–411. 2003.
212.
LiuJ, ChungHJ, VogtM, JinY, MalideD, HeL, DundrM, LevensD. JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress. EMBO J, 30:846–858. 2011.
213.
Livnat-LevanonN, GlickmanMH. Ubiquitin-proteasome system and mitochondria—reciprocity. Biochim Biophys Acta, 1809:80–87. 2011.
214.
LopezSM, MorelliL, CastanoEM, SotoEF, PasquiniJM. Defective ubiquitination of cerebral proteins in Alzheimer's disease. J Neurosci Res, 62:302–310. 2000.
LudersJ, DemandJ, HohfeldJ. The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome. J Biol Chem, 275:4613–4617. 2000.
217.
LukashTO, TurkivskaHV, NegrutskiiBS, El'skayaAV. Chaperone-like activity of mammalian elongation factor eEF1A: renaturation of aminoacyl-tRNA synthetases. Int J Biochem Cell Biol, 36:1341–1347. 2004.
218.
LundgrenJ, MassonP, MirzaeiZ, YoungP. Identification and characterization of a Drosophila proteasome regulatory network. Mol Cell Biol, 25:4662–4675. 2005.
MadsenL, SeegerM, SempleCA, Hartmann-PetersenR. New ATPase regulators—p97 goes to the PUB. Int J Biochem Cell Biol, 41:2380–2388. 2009.
222.
ManciniR, FagioliC, FraAM, MaggioniC, SitiaR. Degradation of unassembled soluble Ig subunits by cytosolic proteasomes: evidence that retrotranslocation and degradation are coupled events. FASEB J, 14:769–778. 2000.
223.
MannhauptG, SchnallR, KarpovV, VetterI, FeldmannH. Rpn4p acts as a transcription factor by binding to PACE, a nonamer box found upstream of 26S proteasomal and other genes in yeast. FEBS Lett, 450:27–34. 1999.
MasdehorsP, Merle-BeralH, MagdelenatH, DelicJ. Ubiquitin-proteasome system and increased sensitivity of B-CLL lymphocytes to apoptotic death activation. Leuk Lymphoma, 38:499–504. 2000.
MatiasAC, RamosPC, DohmenRJ. Chaperone-assisted assembly of the proteasome core particle. Biochem Soc Trans, 38:29–33. 2010.
228.
MatsumotoA, TateishiY, OnoyamaI, OkitaY, NakayamaK, NakayamaKI. 2011. Fbxw7beta resides in the endoplasmic reticulum membrane and protects cells from oxidative stress. Cancer Sci[Epub ahead of print] DOI: 10.1111/j.1349-7006.2011.01851.x.
229.
MatthewsW, DriscollJ, TanakaK, IchiharaA, GoldbergAL. Involvement of the proteasome in various degradative processes in mammalian cells. Proc Natl Acad Sci U S A, 86:2597–2601. 1989.
230.
MazumdarT, GorgunFM, ShaY, TyryshkinA, ZengS, Hartmann-PetersenR, JorgensenJP, HendilKB, EissaNT. Regulation of NF-{kappa}B activity and inducible nitric oxide synthase by regulatory particle non-ATPase subunit 13 (Rpn13)Proc Natl Acad Sci U S A, 107:13854–13859. 2010.
231.
McConkeyDJ, ZhuK. Mechanisms of proteasome inhibitor action and resistance in cancer. Drug Resist Updat, 11:164–179. 2008.
232.
McMahonM, ItohK, YamamotoM, HayesJD. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem, 278:21592–21600. 2003.
233.
McNaughtKS, JennerP. Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci Lett, 297:191–194. 2001.
234.
MedicherlaB, GoldbergAL. Heat shock and oxygen radicals stimulate ubiquitin-dependent degradation mainly of newly synthesized proteins. J Cell Biol, 182:663–673. 2008.
235.
MeinersS, HeykenD, WellerA, LudwigA, StanglK, KloetzelPM, KrugerE. Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of Mammalian proteasomes. J Biol Chem, 278:21517–21525. 2003.
236.
MerkerK, UllrichO, SchmidtH, SitteN, GruneT. Stability of the nuclear protein turnover during cellular senescence of human fibroblasts. FASEB J, 17:1963–1965. 2003.
237.
MetzgerMB, MichaelisS. Analysis of quality control substrates in distinct cellular compartments reveals a unique role for Rpn4p in tolerating misfolded membrane proteins. Mol Biol Cell, 20:1006–1019. 2009.
238.
MeyerHH, ShorterJG, SeemannJ, PappinD, WarrenG. A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways. EMBO J, 19:2181–2192. 2000.
239.
MillerCP, BanK, DujkaME, McConkeyDJ, MunsellM, PalladinoM, ChandraJ. NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells. Blood, 110:267–277. 2007.
240.
MitsuiA, HamuroJ, NakamuraH, KondoN, HirabayashiY, Ishizaki-KoizumiS, HirakawaT, InoueT, YodoiJ. Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxid Redox Signal, 4:693–696. 2002.
241.
MolinariM, CalancaV, GalliC, LuccaP, PaganettiP. Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle. Science, 299:1397–1400. 2003.
242.
MolinariM, GalliC, PiccalugaV, PierenM, PaganettiP. Sequential assistance of molecular chaperones and transient formation of covalent complexes during protein degradation from the ER. J Cell Biol, 158:247–257. 2002.
243.
MorimotoRI, CuervoAM. Protein homeostasis and aging: taking care of proteins from the cradle to the grave. J Gerontol A Biol Sci Med Sci, 64:167–170. 2009.
244.
MurakamiY, MatsufujiS, HayashiS, TanahashiN, TanakaK. Degradation of ornithine decarboxylase by the 26S proteasome. Biochem Biophys Res Commun, 267:1–6. 2000.
245.
MurphyP, KolstoA. Expression of the bZIP transcription factor TCF11 and its potential dimerization partners during development. Mech Dev, 97:141–148. 2000.
246.
MyhrstadMC, HusbergC, MurphyP, NordstromO, BlomhoffR, MoskaugJO, KolstoAB. TCF11/Nrf1 overexpression increases the intracellular glutathione level and can transactivate the gamma-glutamylcysteine synthetase (GCS) heavy subunit promoter. Biochim Biophys Acta, 1517:212–219. 2001.
247.
Nerini-MolteniS, FerrariniM, CozzaS, Caligaris-CappioF, SitiaR. Redox homeostasis modulates the sensitivity of myeloma cells to bortezomib. Br J Haematol, 141:494–503. 2008.
248.
NickellS, BeckF, ScheresSH, KorinekA, ForsterF, LaskerK, MihalacheO, SunN, NagyI, SaliA, PlitzkoJM, CarazoJM, MannM, BaumeisterW. Insights into the molecular architecture of the 26S proteasome. Proc Natl Acad Sci U S A, 106:11943–11947. 2009.
249.
NunomuraA, PerryG, AlievG, HiraiK, TakedaA, BalrajEK, JonesPK, GhanbariH, WatayaT, ShimohamaS, ChibaS, AtwoodCS, PetersenRB, SmithMA. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol, 60:759–767. 2001.
250.
NussbaumAK, Rodriguez-CarrenoMP, BenningN, BottenJ, WhittonJL. Immunoproteasome-deficient mice mount largely normal CD8+ T cell responses to lymphocytic choriomeningitis virus infection and DNA vaccination. J Immunol, 175:1153–1160. 2005.
251.
NystromT. Role of oxidative carbonylation in protein quality control and senescence. EMBO J, 24:1311–1317. 2005.
252.
ObengEA, CarlsonLM, GutmanDM, HarringtonWJJr., LeeKP, BoiseLH. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood, 107:4907–4916. 2006.
253.
ObinM, ShangF, GongX, HandelmanG, BlumbergJ, TaylorA. Redox regulation of ubiquitin-conjugating enzymes: mechanistic insights using the thiol-specific oxidant diamide. FASEB J, 12:561–569. 1998.
254.
OdaY, HosokawaN, WadaI, NagataK. EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin. Science, 299:1394–1397. 2003.
255.
OkadaK, WangpoengtrakulC, OsawaT, ToyokuniS, TanakaK, UchidaK. 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J Biol Chem, 274:23787–23793. 1999.
OrtegaZ, Diaz-HernandezM, MaynardCJ, HernandezF, DantumaNP, LucasJJ. Acute polyglutamine expression in inducible mouse model unravels ubiquitin/proteasome system impairment and permanent recovery attributable to aggregate formation. J Neurosci, 30:3675–3688. 2010.
258.
OteroJH, SuoJ, GordonC, ChangEC. Int6 and Moe1 interact with Cdc48 to regulate ERAD and proper chromosome segregation. Cell Cycle, 9:147–161. 2010.
259.
OwsianikG, BalziIL, GhislainM. Control of 26S proteasome expression by transcription factors regulating multidrug resistance in Saccharomyces cerevisiae. Mol Microbiol, 43:1295–1308. 2002.
260.
Pacifici REDK. A 700-kDa red cell proteinase which selectively degrades oxidativeley denatured hemoglobin. FASEB J, 4135. 1988.
261.
PacificiRE, KonoY, DaviesKJ. Hydrophobicity as the signal for selective degradation of hydroxyl radical-modified hemoglobin by the multicatalytic proteinase complex, proteasome. J Biol Chem, 268:15405–15411. 1993.
262.
PacificiRE, SaloDC, DaviesKJ. Macroxyproteinase (M.O.P.): a 670 kDa proteinase complex that degrades oxidatively denatured proteins in red blood cells. Free Radic Biol Med, 7:521–536. 1989.
263.
ParkJ, KimY, ChungJ. Mitochondrial dysfunction and Parkinson's disease genes: insights from Drosophila. Dis Model Mech, 2:336–340. 2009.
264.
ParolaM, BellomoG, RobinoG, BarreraG, DianzaniMU. 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antioxid Redox Signal, 1:255–284. 1999.
265.
Pearl-YafeM, HalperinD, HalevyA, KalirH, BieloraiB, FabianI. An oxidative mechanism of interferon induced priming of the Fas pathway in Fanconi anemia cells. Biochem Pharmacol, 65:833–842. 2003.
266.
PengJ, SchwartzD, EliasJE, ThoreenCC, ChengD, MarsischkyG, RoelofsJ, FinleyD, GygiSP. A proteomics approach to understanding protein ubiquitination. Nat Biotechnol, 21:921–926. 2003.
267.
PerezVI, BuffensteinR, MasamsettiV, LeonardS, SalmonAB, MeleJ, AndziakB, YangT, EdreyY, FriguetB, WardW, RichardsonA, ChaudhuriA. Protein stability and resistance to oxidative stress are determinants of longevity in the longest-living rodent, the naked mole-rat. Proc Natl Acad Sci U S A, 106:3059–3064. 2009.
268.
Perez-GalanP, RoueG, VillamorN, MontserratE, CampoE, ColomerD. The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood, 107:257–264. 2006.
269.
PickartCM. Mechanisms underlying ubiquitination. Annu Rev Biochem, 70:503–533. 2001.
PickeringAM, KoopAL, TeohCY, ErmakG, GruneT, DaviesKJ. The immunoproteasome, the 20S proteasome, and the PA28alphabeta proteasome regulator are oxidative stress-adaptive proteolytic complexes. Biochem J, 432:585–594. 2010.
272.
PlafkerSM. Oxidative stress and the ubiquitin proteolytic system in age-related macular degeneration. Adv Exp Med Biol, 664:447–456. 2010.
273.
PoppekD, GruneT. Proteasomal defense of oxidative protein modifications. Antioxid Redox Signal, 8:173–184. 2006.
274.
PrattWB, MorishimaY, PengHM, OsawaY. Proposal for a role of the Hsp90/Hsp70-based chaperone machinery in making triage decisions when proteins undergo oxidative and toxic damage. Exp Biol Med (Maywood), 235:278–289. 2010.
275.
PredmoreJM, WangP, DavisF, BartoloneS, WestfallMV, DykeDB, PaganiF, PowellSR, DaySM. Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies. Circulation, 121:997–1004. 2010.
276.
PuttaparthiK, ElliottJL. Non-neuronal induction of immunoproteasome subunits in an ALS model: possible mediation by cytokines. Exp Neurol, 196:441–451. 2005.
277.
QuerfurthHW, LaFerlaFM. Alzheimer's disease. N Engl J Med, 362:329–344. 2010.
278.
RaasiS, WolfDH. Ubiquitin receptors and ERAD: a network of pathways to the proteasome. Semin Cell Dev Biol, 18:780–791. 2007.
279.
RadhakrishnanSK, LeeCS, YoungP, BeskowA, ChanJY, DeshaiesRJ. Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells. Mol Cell, 38:17–28. 2010.
280.
RajanRS, IllingME, BenceNF, KopitoRR. Specificity in intracellular protein aggregation and inclusion body formation. Proc Natl Acad Sci U S A, 98:13060–13065. 2001.
281.
ReinheckelT, GruneT, DaviesKJ. The measurement of protein degradation in response to oxidative stress. Methods Mol Biol, 99:49–60. 2000.
282.
ReinheckelT, SitteN, UllrichO, KuckelkornU, DaviesKJ, GruneT. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J 335 (Pt, 3):637–642. 1998.
283.
ReinheckelT, UllrichO, SitteN, GruneT. Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress. Arch Biochem Biophys, 377:65–68. 2000.
284.
ReitsEA, VosJC, GrommeM, NeefjesJ. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature, 404:774–778. 2000.
285.
Reyes-TurcuFE, VentiiKH, WilkinsonKD. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem, 78:363–397. 2009.
286.
RichlyH, RapeM, BraunS, RumpfS, HoegeC, JentschS. A series of ubiquitin binding factors connects CDC48/p97 to substrate multiubiquitylation and proteasomal targeting. Cell, 120:73–84. 2005.
287.
RivettAJ. Preferential degradation of the oxidatively modified form of glutamine synthetase by intracellular mammalian proteases. J Biol Chem, 260:300–305. 1985.
288.
RotinD, KumarS. Physiological functions of the HECT family of ubiquitin ligases. Nat Rev Mol Cell Biol, 10:398–409. 2009.
289.
RushmoreTH, MortonMR, PickettCB. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem, 266:11632–11639. 1991.
290.
RushworthSA, MacEwanDJ, O'ConnellMA. Lipopolysaccharide-induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes. J Immunol, 181:6730–6737. 2008.
291.
RyuHW, RyuKY. Quantification of oxidative stress in live mouse embryonic fibroblasts by monitoring the responses of polyubiquitin genes. Biochem Biophys Res Commun, 404:470–475. 2011.
292.
SackstederCA, WhittierJE, XiongY, LiJ, GalevaNA, JacobyME, PurvineSO, WilliamsTD, RechsteinerMC, BigelowDJ, SquierTC. Tertiary structural rearrangements upon oxidation of Methionine145 in calmodulin promotes targeted proteasomal degradation. Biophys J, 91:1480–1493. 2006.
293.
SahniSK, RydkinaE, SahniA. The proteasome inhibitor MG132 induces nuclear translocation of erythroid transcription factor Nrf2 and cyclooxygenase-2 expression in human vascular endothelial cells. Thromb Res, 122:820–825. 2008.
294.
SasakiM, IkedaH, SatoY, NakanumaY. Proinflammatory cytokine-induced cellular senescence of biliary epithelial cells is mediated via oxidative stress and activation of ATM pathway: a culture study. Free Radic Res, 42:625–632. 2008.
295.
SchauberC, ChenL, TongaonkarP, VegaI, LambertsonD, PottsW, MaduraK. Rad23 links DNA repair to the ubiquitin/proteasome pathway. Nature, 391:715–718. 1998.
296.
ScheffnerM, HuibregtseJM, VierstraRD, HowleyPM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell, 75:495–505. 1993.
297.
SchreinerP, ChenX, HusnjakK, RandlesL, ZhangN, ElsasserS, FinleyD, DikicI, WaltersKJ, GrollM. Ubiquitin docking at the proteasome through a novel pleckstrin-homology domain interaction. Nature, 453:548–552. 2008.
298.
SchubertU, AntonLC, GibbsJ, NorburyCC, YewdellJW, BenninkJR. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature, 404:770–774. 2000.
299.
SchuberthC, BuchbergerA. UBX domain proteins: major regulators of the AAA ATPase Cdc48/p97. Cell Mol Life Sci, 65:2360–2371. 2008.
300.
SeibenhenerML, BabuJR, GeethaT, WongHC, KrishnaNR, WootenMW. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol, 24:8055–8068. 2004.
SeifertU, KrugerE. Remodelling of the ubiquitin-proteasome system in response to interferons. Biochem Soc Trans, 36:879–884. 2008.
303.
SelkoeDJ. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol, 6:1054–1061. 2004.
304.
SempleCA. The comparative proteomics of ubiquitination in mouse. Genome Res, 13:1389–1394. 2003.
305.
ShaZ, BrillLM, CabreraR, KleifeldO, ScheligaJS, GlickmanMH, ChangEC, WolfDA. The eIF3 interactome reveals the translasome, a supercomplex linking protein synthesis and degradation machineries. Mol Cell, 36:141–152. 2009.
306.
ShahJJ, OrlowskiRZ. Proteasome inhibitors in the treatment of multiple myeloma. Leukemia, 23:1964–1979. 2009.
307.
ShangF, GongX, TaylorA. Activity of ubiquitin-dependent pathway in response to oxidative stress. Ubiquitin-activating enzyme is transiently up-regulated. J Biol Chem, 272:23086–23093. 1997.
308.
ShangF, NowellTRJr., TaylorA. Removal of oxidatively damaged proteins from lens cells by the ubiquitin-proteasome pathway. Exp Eye Res, 73:229–238. 2001.
309.
ShangF, TaylorA. Oxidative stress and recovery from oxidative stress are associated with altered ubiquitin conjugating and proteolytic activities in bovine lens epithelial cells. Biochem J 307 (Pt, 1):297–303. 1995.
310.
ShiH, ShiX, LiuKJ. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol Cell Biochem, 255:67–78. 2004.
ShringarpureR, GruneT, MehlhaseJ, DaviesKJ. Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J Biol Chem, 278:311–318. 2003.
313.
SijtsA, SunY, JanekK, KralS, PaschenA, SchadendorfD, KloetzelPM. The role of the proteasome activator PA28 in MHC class I antigen processing. Mol Immunol, 39:165–169. 2002.
314.
SilvaGM, NettoLE, DiscolaKF, Piassa-FilhoGM, PimentaDC, BarcenaJA, DemasiM. Role of glutaredoxin 2 and cytosolic thioredoxins in cysteinyl-based redox modification of the 20S proteasome. FEBS J, 275:2942–2955. 2008.
315.
SinghS, AwasthiN, EgwuaguCE, WagnerBJ. Immunoproteasome expression in a nonimmune tissue, the ocular lens. Arch Biochem Biophys, 405:147–153. 2002.
316.
SitteN, MerkerK, GruneT. Proteasome-dependent degradation of oxidized proteins in MRC-5 fibroblasts. FEBS Lett, 440:399–402. 1998.
317.
SkaarJR, PaganoM. Control of cell growth by the SCF and APC/C ubiquitin ligases. Curr Opin Cell Biol, 21:816–824. 2009.
318.
SmithDM, ChangSC, ParkS, FinleyD, ChengY, GoldbergAL. Docking of the proteasomal ATPases' carboxyl termini in the 20S proteasome's alpha ring opens the gate for substrate entry. Mol Cell, 27:731–744. 2007.
319.
SollnerS, SchoberM, WagnerA, PremA, LorkovaL, PalfeyBA, GrollM, MacherouxP. Quinone reductase acts as a redox switch of the 20S yeast proteasome. EMBO Rep, 10:65–70. 2009.
320.
SpenceJ, SadisS, HaasAL, FinleyD. A ubiquitin mutant with specific defects in DNA repair and multiubiquitination. Mol Cell Biol, 15:1265–1273. 1995.
321.
SquierTC. Redox modulation of cellular metabolism through targeted degradation of signaling proteins by the proteasome. Antioxid Redox Signal, 8:217–228. 2006.
322.
StackEC, MatsonWR, FerranteRJ. Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants. Ann N Y Acad Sci, 1147:79–92. 2008.
323.
StackEC, SmithKM, RyuH, CormierK, ChenM, HagertySW, Del SignoreSJ, CudkowiczME, FriedlanderRM, FerranteRJ. Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice. Biochim Biophys Acta, 1762:373–380. 2006.
324.
StadtmanER. Protein oxidation and aging. Science, 257:1220–1224. 1992.
325.
StadtmanER, LevineRL. Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids, 25:207–218. 2003.
326.
StadtmanER, MoskovitzJ, LevineRL. Oxidation of methionine residues of proteins: biological consequences. Antioxid Redox Signal, 5:577–582. 2003.
StanhillA, HaynesCM, ZhangY, MinG, SteeleMC, KalininaJ, MartinezE, PickartCM, KongXP, RonD. An arsenite-inducible 19S regulatory particle-associated protein adapts proteasomes to proteotoxicity. Mol Cell, 23:875–885. 2006.
329.
SteffenJ, SeegerM, KochA, KrugerE. Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop. Mol Cell, 40:147–158. 2010.
330.
SterzJ, von MI, HahneJC, LamottkeB, RademacherJ, HeiderU, TerposE, SezerO. The potential of proteasome inhibitors in cancer therapy. Expert Opin Investig Drugs, 17:879–895. 2008.
331.
StrackPR, WaxmanL, FaganJM. Activation of the multicatalytic endopeptidase by oxidants. Effects on enzyme structure. Biochemistry, 35:7142–7149. 1996.
332.
StrackPR, WaxmanL, FaganJM. ATP-stimulated degradation of oxidatively modified superoxide dismutase by cathepsin D in cardiac tissue extracts. Biochem Biophys Res Commun, 219:348–353. 1996.
333.
StrehlB, JoerisT, RiegerM, VisekrunaA, Textoris-TaubeK, KaufmannSH, KloetzelPM, KuckelkornU, SteinhoffU. Immunoproteasomes are essential for clearance of Listeria monocytogenes in nonlymphoid tissues but not for induction of bacteria-specific CD8+ T cells. J Immunol, 177:6238–6244. 2006.
334.
StrehlB, SeifertU, KrugerE, HeinkS, KuckelkornU, KloetzelPM. Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing. Immunol Rev, 207:19–30. 2005.
335.
StricklandE, HakalaK, ThomasPJ, DeMartinoGN. Recognition of misfolding proteins by PA700, the regulatory subcomplex of the 26 S proteasome. J Biol Chem, 275:5565–5572. 2000.
336.
SuzukiT, TanabeK, HaraI, TaniguchiN, ColavitaA. Dual enzymatic properties of the cytoplasmic peptide: N-glycanase in C. elegans. Biochem Biophys Res Commun, 358:837–841. 2007.
337.
SzetoJ, KaniukNA, CanadienV, NismanR, MizushimaN, YoshimoriT, Bazett-JonesDP, BrumellJH. ALIS are stress-induced protein storage compartments for substrates of the proteasome and autophagy. Autophagy, 2:189–199. 2006.
338.
TakedaK, YoshidaT, KikuchiS, NagaoK, KokubuA, PluskalT, Villar-BrionesA, NakamuraT, YanagidaM. Synergistic roles of the proteasome and autophagy for mitochondrial maintenance and chronological lifespan in fission yeast. Proc Natl Acad Sci U S A, 107:3540–3545. 2010.
339.
TanahashiN, MurakamiY, MinamiY, ShimbaraN, HendilKB, TanakaK. Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. J Biol Chem, 275:14336–14345. 2000.
340.
TanakaA, ClelandMM, XuS, NarendraDP, SuenDF, KarbowskiM, YouleRJ. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol, 191:1367–1380. 2010.
341.
TanakaK, IiK, IchiharaA, WaxmanL, GoldbergAL. A high molecular weight protease in the cytosol of rat liver. I. Purification, enzymological properties, and tissue distribution. J Biol Chem, 261:15197–15203. 1986.
342.
TarcsaE, SzymanskaG, LeckerS, O'ConnorCM, GoldbergAL. Ca2+-free calmodulin and calmodulin damaged by in vitro aging are selectively degraded by 26 S proteasomes without ubiquitination. J Biol Chem, 275:20295–20301. 2000.
343.
TatebeH, YanagidaM. Cut8, essential for anaphase, controls localization of 26S proteasome, facilitating destruction of cyclin and Cut2. Curr Biol, 10:1329–1338. 2000.
344.
TathamMH, GeoffroyMC, ShenL, PlechanovovaA, HattersleyN, JaffrayEG, PalvimoJJ, HayRT. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol, 10:538–546. 2008.
345.
TeohCY, DaviesKJ. Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the ’PrOxI ’ hypothesis. Arch Biochem Biophys, 423:88–96. 2004.
346.
ThompsonD, HakalaK, DeMartinoGN. Subcomplexes of PA700, the 19 S regulator of the 26 S proteasome, reveal relative roles of AAA subunits in 26 S proteasome assembly and activation and ATPase activity. J Biol Chem, 284:24891–24903. 2009.
347.
ThornalleyPJ, BattahS, AhmedN, KarachaliasN, AgalouS, Babaei-JadidiR, DawnayA. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J, 375:581–592. 2003.
348.
ThrowerJS, HoffmanL, RechsteinerM, PickartCM. Recognition of the polyubiquitin proteolytic signal. EMBO J, 19:94–102. 2000.
349.
ToesRE, NussbaumAK, DegermannS, SchirleM, EmmerichNP, KraftM, LaplaceC, ZwindermanA, DickTP, MullerJ, SchonfischB, SchmidC, FehlingHJ, StevanovicS, RammenseeHG, SchildH. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J Exp Med, 194:1–12. 2001.
350.
TokunagaF, SakataS, SaekiY, SatomiY, KirisakoT, KameiK, NakagawaT, KatoM, MurataS, YamaokaS, YamamotoM, AkiraS, TakaoT, TanakaK, IwaiK. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol, 11:123–132. 2009.
351.
TomkoRJJr., FunakoshiM, SchneiderK, WangJ, HochstrasserM. Heterohexameric ring arrangement of the eukaryotic proteasomal ATPases: implications for proteasome structure and assembly. Mol Cell, 38:393–403. 2010.
352.
TongKI, KatohY, KusunokiH, ItohK, TanakaT, YamamotoM. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol Cell Biol, 26:2887–2900. 2006.
353.
TouitouR, RichardsonJ, BoseS, NakanishiM, RivettJ, AlldayMJ. A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J, 20:2367–2375. 2001.
354.
UchidaK. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res, 42:318–343. 2003.
355.
UshiodaR, HosekiJ, ArakiK, JansenG, ThomasDY, NagataK. ERdj5 is required as a disulfide reductase for degradation of misfolded proteins in the ER. Science, 321:569–572. 2008.
356.
VabulasRM, HartlFU. Protein synthesis upon acute nutrient restriction relies on proteasome function. Science, 310:1960–1963. 2005.
357.
ValkoM, LeibfritzD, MoncolJ, CroninMT, MazurM, TelserJ. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol, 39:44–84. 2007.
358.
Van der VeenAG, SchorppK, SchliekerC, ButiL, DamonJR, SpoonerE, PloeghHL, JentschS. Role of the ubiquitin-like protein Urm1 as a noncanonical lysine-directed protein modifier. Proc Natl Acad Sci U S A, 108:1763–1770. 2011.
359.
VembarSS, BrodskyJL. One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol, 9:944–957. 2008.
360.
VenugopalR, JaiswalAK. Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene, 17:3145–3156. 1998.
361.
VermaR, AravindL, OaniaR, McDonaldWH, YatesJRIII, KooninEV, DeshaiesRJ. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science, 298:611–615. 2002.
362.
VermaR, OaniaR, GraumannJ, DeshaiesRJ. Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system. Cell, 118:99–110. 2004.
363.
VernaceVA, Schmidt-GlenewinkelT, Figueiredo-PereiraME. Aging and regulated protein degradation: who has the UPPer hand?Aging Cell, 6:599–606. 2007.
364.
Vijay-KumarS, BuggCE, WilkinsonKD, CookWJ. Three-dimensional structure of ubiquitin at 2.8 A resolution. Proc Natl Acad Sci U S A, 82:3582–3585. 1985.
365.
VilleneuveNF, LauA, ZhangDD. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. Antioxid Redox Signal, 13:1699–1712. 2010.
366.
Vives-BauzaC, de VriesRL, TocilescuM, PrzedborskiS. PINK1/Parkin direct mitochondria to autophagy. Autophagy, 6:315–316. 2010.
WangW, ChanJY. Nrf1 is targeted to the endoplasmic reticulum membrane by an N-terminal transmembrane domain. Inhibition of nuclear translocation and transacting function. J Biol Chem, 281:19676–19687. 2006.
WangX, XuH, JuD, XieY. Disruption of Rpn4-induced proteasome expression in Saccharomyces cerevisiae reduces cell viability under stressed conditions. Genetics, 180:1945–1953. 2008.
371.
WangX, YenJ, KaiserP, HuangL. Regulation of the 26S proteasome complex during oxidative stress. Sci Signal, 3:ra88. 2010.
372.
WatanabeY, SuzukiO, HaruyamaT, AkaikeT. Interferon-gamma induces reactive oxygen species and endoplasmic reticulum stress at the hepatic apoptosis. J Cell Biochem, 89:244–253. 2003.
373.
WenzelT, BaumeisterW. Conformational constraints in protein degradation by the 20S proteasome. Nat Struct Biol, 2:199–204. 1995.
374.
WestphalK, StanglV, FahlingM, DregerH, WellerA, BaumannG, StanglK, MeinersS. Human-specific induction of glutathione peroxidase-3 by proteasome inhibition in cardiovascular cells. Free Radic Biol Med, 47:1652–1660. 2009.
375.
WhitbyFG, MastersEI, KramerL, KnowltonJR, YaoY, WangCC, HillCP. Structural basis for the activation of 20S proteasomes by 11S regulators. Nature, 408:115–120. 2000.
376.
WhiteE, KarpC, StroheckerAM, GuoY, MathewR. Role of autophagy in suppression of inflammation and cancer. Curr Opin Cell Biol, 22:212–217. 2010.
377.
WhittierJE, XiongY, RechsteinerMC, SquierTC. Hsp90 enhances degradation of oxidized calmodulin by the 20 S proteasome. J Biol Chem, 279:46135–46142. 2004.
378.
WigleyWC, FabunmiRP, LeeMG, MarinoCR, MuallemS, DeMartinoGN, ThomasPJ. Dynamic association of proteasomal machinery with the centrosome. J Cell Biol, 145:481–490. 1999.
379.
WilkinsonCR, SeegerM, Hartmann-PetersenR, StoneM, WallaceM, SempleC, GordonC. Proteins containing the UBA domain are able to bind to multi-ubiquitin chains. Nat Cell Biol, 3:939–943. 2001.
380.
WisemanRL, ChinKT, HaynesCM, StanhillA, XuCF, RoguevA, KroganNJ, NeubertTA, RonD. Thioredoxin-related Protein 32 is an arsenite-regulated Thiol Reductase of the proteasome 19 S particle. J Biol Chem, 284:15233–15245. 2009.
381.
WojcikC, SchroeterD, WilkS, LamprechtJ, PaweletzN. Ubiquitin-mediated proteolysis centers in HeLa cells: indication from studies of an inhibitor of the chymotrypsin-like activity of the proteasome. Eur J Cell Biol, 71:311–318. 1996.
382.
WojcikC, YanoM, DeMartinoGN. RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysis. J Cell Sci, 117:281–292. 2004.
383.
WongCM, MarcocciL, LiuL, SuzukiYJ. Cell signaling by protein carbonylation and decarbonylation. Antioxid Redox Signal, 12:393–404. 2010.
384.
XieY, VarshavskyA. RPN4 is a ligand, substrate, and transcriptional regulator of the 26S proteasome: a negative feedback circuit. Proc Natl Acad Sci U S A, 98:3056–3061. 2001.
385.
XuZ, ChenL, LeungL, YenTS, LeeC, ChanJY. Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. Proc Natl Acad Sci U S A, 102:4120–4125. 2005.
386.
YamanakaK, IshikawaH, MegumiY, TokunagaF, KanieM, RouaultTA, MorishimaI, MinatoN, IshimoriK, IwaiK. Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2. Nat Cell Biol, 5:336–340. 2003.
387.
YaoT, CohenRE. A cryptic protease couples deubiquitination and degradation by the proteasome. Nature, 419:403–407. 2002.
388.
YaoZ, WoodNW. Cell death pathways in Parkinson's disease: role of mitochondria. Antioxid Redox Signal, 11:2135–2149. 2009.
389.
YeY, ShibataY, KikkertM, vanVS, WiertzE, RapoportTA. Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane. Proc Natl Acad Sci U S A, 102:14132–14138. 2005.
390.
YeY, ShibataY, YunC, RonD, RapoportTA. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature, 429:841–847. 2004.
391.
YewdellJW. The seven dirty little secrets of major histocompatibility complex class I antigen processing. Immunol Rev, 207:8–18. 2005.
392.
YewdellJW, AntonLC, BenninkJR. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?J Immunol, 157:1823–1826. 1996.
393.
YewdellJW, NicchittaCV. The DRiP hypothesis decennial: support, controversy, refinement and extension. Trends Immunol, 27:368–373. 2006.
YunC, StanhillA, YangY, ZhangY, HaynesCM, XuCF, NeubertTA, MorA, PhilipsMR, RonD. Proteasomal adaptation to environmental stress links resistance to proteotoxicity with longevity in Caenorhabditis elegans. Proc Natl Acad Sci U S A, 105:7094–7099. 2008.
396.
ZhangDD, LoSC, CrossJV, TempletonDJ, HanninkM. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol, 24:10941–10953. 2004.
397.
ZhangQ, PiJ, WoodsCG, AndersenME. A systems biology perspective on Nrf2-mediated antioxidant response. Toxicol Appl Pharmacol, 244:84–97. 2010.
398.
ZhangY, LucocqJM, HayesJD. The Nrf1 CNC/bZIP protein is a nuclear envelope-bound transcription factor that is activated by t-butyl hydroquinone but not by endoplasmic reticulum stressors. Biochem J, 418:293–310. 2009.
399.
ZhengPZ, WangKK, ZhangQY, HuangQH, DuYZ, ZhangQH, XiaoDK, ShenSH, ImbeaudS, EvenoE, ZhaoCJ, ChenYL, FanHY, WaxmanS, AuffrayC, JinG, ChenSJ, ChenZ, ZhangJ. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc Natl Acad Sci U S A, 102:7653–7658. 2005.
400.
ZmijewskiJW, BanerjeeS, AbrahamE. S-glutathionylation of the Rpn2 regulatory subunit inhibits 26 S proteasomal function. J Biol Chem, 284:22213–22221. 2009.
ZouW, YueP, LinN, HeM, ZhouZ, LonialS, KhuriFR, WangB, SunSY. Vitamin C inactivates the proteasome inhibitor PS-341 in human cancer cells. Clin Cancer Res, 12:273–280. 2006.
